Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Cholangiocarcinoma × Liver Transplantation × Clear all

Phase

Status

Recruiting 3 Terminated 2 Unknown 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 3 Liver Neoplasms 2 Klatskin Tumor 2 Carcinoma, Hepatocellular 2 Neuroendocrine Tumors 1 Neoplasms 1 Liver Diseases 1 Gastrointestinal Stromal Tumors 1 Colorectal Neoplasms 1 Colorectal Liver Metastases 1 Colonic Neoplasms 1 Cholangitis, Sclerosing 1 Cholangiocarcinoma 1

Interventions

Gemcitabine 11 Oxaliplatin 7 Capecitabine 6 apatinib 5 tislelizumab 4 Radiofrequency Ablation 4 Fluorouracil 4 Cisplatin 4 sintilimab 3 lenvatinib 3 Surgical Procedures, Operative 3 Neoadjuvant Therapy 3 Leucovorin 3 Irinotecan 3 toripalimab 2 camrelizumab 2 Stents 2 Radiotherapy 2 Photochemotherapy 2 Immunotherapy 2 Hepatectomy 2 Everolimus 2 Cholangiopancreatography, Endoscopic Retrograde 2 Blood Specimen Collection 2 surufatinib 1 regorafenib 1 pemigatinib 1 niraparib 1 durvalumab 1 apixaban 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02232932 2021-11-03

TRANSPHIL

Assistance Publique - Hôpitaux de Paris

Phase NA Unknown

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡